Filing Details
- Accession Number:
- 0001835830-24-000095
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-18 17:41:24
- Reporting Period:
- 2024-09-16
- Accepted Time:
- 2024-09-18 17:41:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1835830 | Klaviyo Inc. | KVYO | Services-Prepackaged Software (7372) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1991400 | Allen Chaves | C/O Klaviyo, Inc. 125 Summer Street 6Th Floor Boston MA 02110 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Series A Common Stock | Acquisiton | 2024-09-16 | 130,000 | $0.00 | 130,000 | No | 4 | C | Direct | |
| Series A Common Stock | Disposition | 2024-09-16 | 101,066 | $32.03 | 28,934 | No | 4 | S | Direct | |
| Series A Common Stock | Disposition | 2024-09-16 | 28,934 | $31.21 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Series B Common Stock | Stock Option (Right to Buy) | Disposition | 2024-09-16 | 130,000 | $0.00 | 130,000 | $3.06 |
| Series A Common Stock | Series B Common Stock | Acquisiton | 2024-09-16 | 130,000 | $0.00 | 130,000 | $0.00 |
| Series A Common Stock | Series B Common Stock | Disposition | 2024-09-16 | 130,000 | $0.00 | 130,000 | $0.00 |
| Series B Common Stock | Stock Option (Right to Buy) | Disposition | 2024-09-17 | 32,733 | $0.00 | 32,733 | $3.06 |
| Series A Common Stock | Series B Common Stock | Acquisiton | 2024-09-17 | 32,733 | $0.00 | 32,733 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,028,693 | 2030-04-15 | No | 4 | M | Direct | |
| 356,314 | No | 4 | M | Direct | ||
| 226,314 | No | 4 | C | Direct | ||
| 995,960 | 2030-04-15 | No | 4 | M | Direct | |
| 259,047 | No | 4 | M | Direct |
Footnotes
- These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 21, 2023.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.50 to $32.50 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.65 to $31.49 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The shares underlying this option are fully vested and exercisable by the Reporting Person as of the date hereof.
- Each share of Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), of the Issuer, and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.
- Consists of (i) 178,203 shares of Series B Common Stock and (ii) 80,844 unvested restricted stock units awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement.
Billionaire Hedge Funds
